[16, 17] There is increasing evidence that FHL3 is also abnormally expressed in tumor tissues, affecting the progression and prognosis of various cancers such as gastric cancer, pancreatic cancer, and colorectal cancer. This evidence concerns the gene FHL3 and neoplasm.